WBD Still Prices a Regulatory Break After the Vote

Summary: Warner Bros. Discovery traded at $27.12 during this run, while Paramount Skydance's signed cash merger price is $31.00 per WBD share, plus any applicable ticking fee after September 30, 2026. The stockholder vote is done. The U.S. HSR waiting period has expired. The remaining spread is not about whether shareholders want the deal. It is about whether a $110 billion enterprise-value media merger clears the remaining regulatory and closing conditions without a break.

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Warner Bros. Discovery / Paramount Skydance cash merger spread	liquid U.S. large-cap / merger arbitrage / regulatory	WBD traded at $27.12 against a signed $31.00 cash consideration after stockholder approval and HSR expiration, leaving a 14.3% gross spread on a liquid line.	Finance quote latest trade May 8, 2026 at 10:20:49 UTC; WBD Q1 release dated May 6; stockholder approval dated April 23; HSR update dated February 20.	Q3 2026 expected close, remaining regulatory approvals, possible ticking fee after September 30, and any adverse regulator or court action.	About +14.3% to cash consideration before fees, with a moderate EV if the true break probability is below the roughly 32% implied by a $19 break-price anchor.	The deal is large, political, international, and horizontal enough that the regulatory break tail is real.
2	European Opportunities Trust conditional tender trigger	non-U.S. investment trust / tender discount / performance trigger	EOT's promised 25% tender at NAV less 2% becomes live if NAV total return fails to beat the MSCI Europe Index over the three-year period ending May 31, 2026.	HL showed estimated NAV of 912.11p and a -4.95% discount in its latest crawled snapshot; Investegate tender terms and QuotedData notes define the trigger.	May 31, 2026 performance measurement date, 2026 AGM continuation vote, then possible tender implementation.	Tender mechanics can monetize part of the discount, but only for 25% of shares and with proration risk.	The setup overlaps with repeated closed-end fund tender frames and has weaker current price freshness than WBD.
3	Toro Corp special dividend election	microcap shipping / scrip dividend / entitlement mechanics	TORO traded at $5.45 while record holders face a $0.90 cash-or-share dividend election using a $3.8821 calculation value.	Finance quote latest trade May 8, 2026 at 00:15:00 UTC; May 5 Form 6-K election notice; April 22 dividend announcement.	May 22 election deadline, June 4 company override right, June 5 payment date.	The share election can create dilution and entitlement confusion, but the record date has already passed.	Tradeability is poor, the company can override elections, and current buyers may not own the dividend right.

Selected opportunity: Warner Bros. Discovery, NASDAQ: WBD, against Paramount Skydance's signed all-cash merger.

Why this one now: The spread is still wide after two gating events that should matter: WBD stockholders approved the transaction, and Paramount disclosed that the U.S. HSR waiting period expired after DOJ Second Request compliance. That leaves the market charging a visible price for residual regulatory, political, timing, and financing risk.

What should surprise the reader: The surprise is not that a mega-media merger has risk. The surprise is that the stock still offers a double-digit gross spread after the shareholder vote and U.S. HSR expiry, while the remaining consideration is cash, not acquirer stock.

Why This Is the Best Opportunity Right Now

The best idea in this screen is the least obscure one. That is usually a warning. Here it is the edge.

EOT has a real conditional tender, but the setup repeats the closed-end fund discount lane and the payoff is capped by a 25% tender. TORO has a cleaner mechanical oddity, but the record date has passed and the issuer keeps discretion over the dividend form. WBD is cleaner for a daily note because the price, consideration, approvals already obtained, remaining risk, and trade expression are all visible.

At $27.12, the market is not asleep. It is saying the $31.00 cash price is not cash-equivalent because the deal can still fail or stretch. The mispricing claim is narrower: after stockholder approval and HSR expiry, the spread looks too punitive if the break price is not below the high teens.

The Setup

Paramount Skydance agreed to acquire Warner Bros. Discovery for $31.00 per WBD share in cash. WBD's March 26 meeting release said the deal was expected to close in Q3 2026, subject to regulatory clearances and other customary closing conditions, and that WBD holders would receive a $0.25 per share quarterly ticking fee, accruing daily, if the transaction had not closed by September 30, 2026.

WBD stockholders approved the transaction on April 23, 2026. Paramount also disclosed that the HSR waiting period expired on February 19, 2026 at 11:59 p.m. Eastern Time, after certification of compliance with the DOJ's Second Request, and said this meant there was no statutory impediment in the U.S. to closing the proposed acquisition. That does not clear every condition. It does remove one major U.S. gate.

The market facts are tight enough to underwrite:

Market Level	Value	Timestamp / Source	Why It Matters
WBD latest stock price	$27.12	Finance quote latest trade May 8, 2026 at 10:20:49 UTC, 17:20:49 Asia/Ho_Chi_Minh	Current reference price for the spread.
WBD market cap	$67.583 billion	Finance quote latest trade May 8, 2026 at 10:20:49 UTC	Implies roughly 2.49 billion shares at the current price.
Paramount cash consideration	$31.00 per WBD share	WBD March 26 meeting release and Paramount transaction presentation	Signed cash value per WBD share.
Gross spread to $31.00	$3.88, or 14.3%	Calculated from $27.12 versus $31.00	The tradable disagreement.
Ticking fee	$0.25 per share quarterly, accruing daily after September 30, 2026	WBD March 26 meeting release and Paramount transaction presentation	Compensates some timing delay if close slips past Q3.
Expected close	Q3 2026	WBD March 26 meeting release and WBD proxy statement	Sets the base-case timing.
WBD stockholder approval	Approved April 23, 2026	WBD April 23 approval release and WBD proxy statement	Removes the shareholder-vote condition.
U.S. HSR status	Waiting period expired February 19, 2026; no statutory impediment in the U.S. to closing	Paramount February 20 Form 8-K	Reduces, but does not eliminate, regulatory risk.
Regulatory termination fee	$7.0 billion, payable by PSKY if the transaction does not close due to regulatory matters	WBD February 24 revised-proposal release	Cushions one break path, but does not make the downside a floor.
Transaction value	$81 billion equity value and $110 billion enterprise value	Paramount transaction presentation	Explains why regulators and politicians still matter.
Funding	$47 billion new equity investment from the Ellison family and RedBird, plus $54 billion bridge financing	Paramount transaction presentation	Makes financing observable, but large.
PSKY latest stock price	$10.76	Finance quote latest trade May 8, 2026 at 08:00:19 UTC	Acquirer stock weakness is a signal of market discomfort, even though WBD consideration is cash.
PSKY equity investment price	$16.02 per PSKY share	Paramount transaction presentation	Shows the sponsor financing price sits above the current PSKY quote.
WBD Q1 2026 revenue	$8.893 billion	WBD Q1 2026 earnings release dated May 6	Standalone operating scale.
WBD Q1 2026 adjusted EBITDA	$2.203 billion	WBD Q1 2026 earnings release dated May 6	Core earnings base if the deal breaks.
WBD Q1 2026 free cash flow	-$476 million	WBD Q1 2026 earnings release dated May 6	Standalone downside is not clean.
WBD net debt and leverage	$30.1 billion net debt; 3.4x net leverage	WBD Q1 2026 earnings release dated May 6	Balance-sheet risk in the break case.

The deal is not de-risked. It is de-risked enough that the remaining spread deserves a more precise probability than "mega-merger risky."

The Mispricing

The market appears to be pricing WBD as a regulatory-break spread with a large residual tail. That is not irrational. The transaction would combine Paramount, Warner Bros., HBO, CNN, CBS, large studio libraries, linear networks, and streaming assets inside one capital structure. The enterprise value is roughly $110 billion. Regulators outside the U.S. still matter. Political scrutiny can still change the path.

The variant view is that the current price overstates the residual break probability after the two most mechanical gates have cleared. WBD holders approved the transaction. Paramount says the U.S. HSR waiting period expired after Second Request compliance. The cash consideration is not tied to PSKY share exchange value. A daily ticking fee starts after September 30 if the transaction has not closed.

If the break price is $19, the $27.12 market price implies roughly a 68% probability of receiving $31.00 before costs. That leaves about 32% for failure or a materially worse path. A high-20s failure probability is not absurd for this deal. The mispricing is that the true probability may now be closer to 80% after the vote and HSR update, while the downside is cushioned by WBD's real assets and EBITDA base, not protected by them.

Price

The visible spread is $3.88 per share, or 14.3% to the $31.00 cash price. If the deal closes around the end of Q3, that is a large annualized spread for a security with deep daily liquidity. If the deal slips into late 2026 or early 2027, the ticking fee improves the nominal cash value but introduces more headline duration.

The break case matters more than the quoted upside. WBD was an asset-sale and separation story before Paramount won the deal process. The proxy says WBD began evaluating strategic alternatives in October 2025, including continuing the separation, selling the whole company, selling parts, or using an alternative separation structure. That gives the break case some strategic optionality.

It does not give the break case a floor. The $7.0 billion regulatory termination fee helps one specific failure path, but timing, tax, litigation, and non-regulatory failure paths still matter. WBD's Q1 release showed $30.1 billion of net debt, 3.4x net leverage, and negative free cash flow of $476 million in the quarter. If regulators block the transaction, the stock would not simply trade as a clean media compounder. It would trade as a leveraged media company with declining linear exposure, studio cyclicality, and another strategic reset.

That is why the trade is a spread, not a value investment.

Positioning

The clearest positioning evidence is the price itself. WBD is not trading near cash value after stockholder approval and HSR expiration. Merger-arb capital is either unwilling to size the remaining regulatory risk, capped by mandate constraints, or demanding a high return for the path risk.

PSKY's own stock adds a second signal. The finance snapshot put PSKY at $10.76, while the Paramount presentation describes new PSKY Class B equity investment priced at $16.02 per share for the Ellison family and RedBird. That does not mechanically impair the WBD cash consideration, because the transaction funding is described as fully backstopped. It does show that public market capital is skeptical about the acquirer-side economics.

What is not verified: current WBD short interest, borrow cost, options open interest, exact merger-arb ownership, and live dealer positioning. The positioning claim must therefore stay modest. The spread is visibly underwritten as a risky event, but the exact holder map is not fully proven in this run.

Catalyst

The immediate shareholder catalyst is complete. The remaining catalysts are regulatory and procedural:

Remaining non-U.S. regulatory clearances, including jurisdictions where pre-notification or review may continue.
Any public regulator challenge, lawsuit, consent remedy, or phase-two style review.
Confirmation that the Q3 2026 closing target remains intact.
The September 30 ticking-fee date if the deal is delayed.
Acquirer funding steps, including the equity and debt financing described in Paramount materials.

The important point is that the next catalyst may not be a single scheduled vote. It may be the absence of bad news. That makes the trade psychologically harder than a dated tender or meeting vote. The spread can earn slowly until it breaks quickly.

Payoff Map

The cleanest expression is long WBD common. This is an all-cash merger spread. Shorting PSKY is not a natural hedge for the consideration because WBD holders receive cash, not PSKY shares. A media-index hedge can reduce broad beta but will not protect against a deal-specific break. Options can define downside, but the timing distribution is poor: a regulatory delay, closing extension, or late clearance can make short-dated calls or puts the wrong tool even when the directional thesis is right.

One possible expression is a small, unlevered long WBD common position held against the closing process, with immediate re-underwriting on any regulator challenge, financing change, or withdrawal of Q3 closing guidance.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	20%	$31.40	+15.8% before tax, bid/ask spread, borrow, hedge costs, and execution costs	5 to 10 months	Deal closes after September 30, 2026 with some daily ticking fee accrued, or the market prices near-certain closing before the final close date.	Medium
Base Case	60%	$31.00	+14.3% before tax, bid/ask spread, borrow, hedge costs, and execution costs	Q3 to Q4 2026	Remaining regulatory approvals arrive without a blocking remedy, funding proceeds as described, and the signed cash consideration closes.	Medium
Bottom Case	20%	$19.00	-29.9% before tax, bid/ask spread, borrow, hedge costs, and execution costs	Immediate to 12 months	A regulator blocks, litigates, or delays the transaction enough to break the deal, or financing and closing conditions are impaired.	Medium
Invalidation / Stop Condition	n/a	Regulator challenge, formal remedy that changes economics, deal termination, withdrawal of Q3 closing expectation, or WBD below $24 on deal-specific news	Thesis break or full re-underwrite	Immediate	The spread is no longer a timing and clearance trade; it becomes a broken-deal or standalone WBD trade.	High

Probability-weighted expected value: $28.68, about +5.8% versus $27.12, before tax, spreads, hedging costs, and gap risk. EV is computed as 20% * $31.40 + 60% * $31.00 + 20% * $19.00.

Current market price / level: WBD $27.12; signed cash consideration $31.00; gross spread $3.88, or 14.3%.

Timestamp: Market data checked May 8, 2026 at 10:20:49 UTC for WBD, equivalent to 17:20:49 Asia/Ho_Chi_Minh. PSKY quote checked May 8, 2026 at 08:00:19 UTC.

Primary instrument: Warner Bros. Discovery common stock, NASDAQ: WBD.

Alternative expressions considered: Wait for more regulatory clarity; use WBD call spreads; pair long WBD with a media or market hedge; short PSKY against long WBD; avoid the trade. Waiting lowers break risk but may forfeit most of the spread. Options add timing decay. A market hedge does not cover deal-specific regulatory loss. Short PSKY is not a clean hedge because the WBD consideration is cash.

Confidence: Medium. The price, merger terms, shareholder approval, HSR update, transaction funding description, Q1 financials, and spread math are sourced. Remaining regulator behavior, acquirer financing execution, and live arbitrage positioning are uncertain.

What Would Prove This Wrong

This fails first if a regulator sues, demands a remedy that changes the economics, or delays the process beyond what the ticking fee compensates. HSR expiry is not global clearance.

It also fails if Paramount's financing package changes in a way that weakens closing certainty. The presentation describes large equity and debt commitments. Large committed financing is not the same as small financing risk.

The third failure mode is standalone WBD. If the deal breaks while WBD is still printing negative free cash flow, high leverage, and declining linear-network economics, the stock can trade far below a simplistic strategic-alternative floor. Owning WBD for the spread is not the same as owning WBD for the standalone business.

Risk Audit

Strongest counterargument: The market may be correctly pricing the largest all-cash media transaction in the current cycle as a regulatory and political minefield. A 14.3% gross spread is not wide if the true break probability is near one-third.

Most fragile assumption: The load-bearing assumption is that stockholder approval and HSR expiry materially lower the true failure probability. If the remaining non-U.S. reviews or political pressure are the real bottleneck, the spread is fair.

What the market may already know: Everyone can see $31.00 cash, HSR expiry, the vote result, and the Q3 close target. The edge is not hidden information. It is a probability judgment that the market is still charging too much for residual deal risk.

What could make the trade lose money even if the thesis is directionally right: A regulator could extend review without killing the transaction, leaving capital trapped; the stock could sell off on a headline before any final decision; or PSKY financing headlines could widen the spread even if closing remains likely.

Liquidity / execution risks: WBD is liquid, but event gaps matter. The spread can move outside normal bid/ask logic on regulatory news.

Leverage risks: Leverage is a poor fit. The downside is discontinuous.

Information reliability risks: The finance quote gives a point-in-time price. Full real-time order book, borrow, options skew, merger-arb ownership, and complete international clearance status were not verified.

Invalidation trigger: A regulator challenge, a required remedy that changes deal economics, a financing impairment, termination, WBD management withdrawing the Q3 closing expectation, or WBD falling below $24 on deal-specific news.

Publish / revise / reject recommendation: Publish as a medium-confidence cash merger-spread note, not as a standalone media-stock recommendation.

Best Trade Strategy

The clean expression is long WBD common as a merger-arbitrage spread. It is not a short. It is not primarily an options trade. Options can cap downside, but they introduce expiry risk around a regulatory clock that may slip. The common stock is cleaner because the upside is a cash closing payment, while the downside is a deal-break equity reset.

The trade should be sized as an event-risk position and re-underwritten immediately on any regulatory challenge. If the transaction breaks, the thesis changes into a leveraged standalone media turnaround. That is a different trade.

Bottom Line

WBD is not mispriced because the $31.00 cash price is hidden. It is mispriced only if the market is still assigning too much weight to a regulatory break after shareholder approval and U.S. HSR expiry. The setup is liquid, current, and measurable. The price is paying for fear that is real, but possibly overcharged.

Sources

Source	Date	Use
Finance quote used in this run	WBD latest trade May 8, 2026 at 10:20:49 UTC; PSKY latest trade May 8, 2026 at 08:00:19 UTC; TORO latest trade May 8, 2026 at 00:15:00 UTC	Current WBD, PSKY, and TORO price references for spread and candidate screening.
WBD stockholder approval release	2026-04-23	Stockholder approval and deal milestone.
WBD shareholder meeting release	2026-03-26	$31.00 cash consideration, Q3 2026 expected close, ticking fee, and unaffected price reference.
WBD definitive merger proxy	2026-03-26	Strategic alternatives history, $31.00 plus ticking fee, stockholder approval, and remaining regulatory conditions.
WBD revised Paramount proposal release	2026-02-24	$7.0 billion regulatory termination fee and revised Paramount proposal terms.
Paramount transaction presentation	2026-04	$31.00 consideration, $81 billion equity value, $110 billion enterprise value, funding package, Q3 close target, ticking fee, and EU pre-notification reference.
Paramount Form 8-K on HSR expiration	2026-02-20	HSR waiting-period expiry after DOJ Second Request compliance and German foreign investment clearance.
WBD Q1 2026 earnings release	2026-05-06	Revenue, adjusted EBITDA, free cash flow, net debt, leverage, and share count.
European Opportunities conditional tender announcement, Investegate	2023-10-12	Candidate-screen evidence for EOT's performance-related tender mechanics.
European Opportunities quote and NAV page, Hargreaves Lansdown	Crawled 2026-05	Candidate-screen NAV and discount reference.
Toro Corp May 5 Form 6-K	2026-05-05	Candidate-screen election notice for TORO special dividend mechanics.

Research Quality Scorecard

The Research Quality Scorecard, editable source tables, section-17 quality gate, packaging notes, internal audit trail, and cover illustration brief are preserved in the companion meta file.